Selegiline + levodopa: no increase in mortality in PD

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1274, 2001-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Levodopa/pramipexole/selegiline: Gambling: case report

By  

Reactions Weekly, Vol. 1, Iss. 1294, 2010-01 ,pp. : 24-24

Adis International

Access to resources Recommend Favorite

Levodopa in PD: sustaining the long-duration response

By  

Inpharma, Vol. 1, Iss. 1245, 2000-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Ropinirole warranted versus levodopa/benserazide in PD

By  

Inpharma, Vol. 1, Iss. 1375, 2003-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Ropinirole warranted versus levodopa/benserazide in PD

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 400, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

No increase in HF risk or mortality with thiazolidinediones

By  

Reactions Weekly, Vol. 1, Iss. 1160, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite